Company Filing History:
Years Active: 2024
Title: Zhenyu Li: Innovator in Bispecific Antibody Technology
Introduction
Zhenyu Li is a prominent inventor based in Linyi, China. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. His innovative work aims to enhance cancer treatment through targeted therapies.
Latest Patents
Zhenyu Li holds a patent for a bispecific antibody that binds to BCMA and CD3. This invention relates to methods and uses of a bispecific antibody that specifically targets the CD3 surface antigen on immune cells and the BCMA antigen on tumor cells. The antibody is designed to bind human CD3 with high affinity, induce T cell proliferation, and mediate tumor cell killing effects. This bispecific antibody has potential applications in mediating T cell-specific killing of target cells in in vitro tests.
Career Highlights
Zhenyu Li is associated with Shandong New Time Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest for effective cancer therapies.
Collaborations
Zhenyu Li collaborates with notable colleagues, including Qiang Li and Shixiang Jia, to further enhance the impact of his research in the pharmaceutical industry.
Conclusion
Zhenyu Li's innovative contributions to bispecific antibody technology represent a significant advancement in cancer treatment. His work continues to inspire future research and development in the field.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.